VISTAGEN THERAPEUTICS INC (VTGN) Stock Earnings & Estimates
NASDAQ:VTGN - US92840H4002 - Common Stock
3.17 USD
+0.11 (+3.59%)
3.23 USD
+0.06 (+1.89%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -230K -120.72% | 1.064M 562.61% | 486K -54.32% | 714K 46.91% | 4.315M 504.34% | 69.518M 1,511.08% | 142.99M 105.69% | 308.97M 116.08% | 880.53M 184.99% | 1.251B 42.07% | |
| EBITDA YoY % growth | -59.14M -24.17% | -32.453M 45.13% | -55.338M -70.52% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -59.27M -24.05% | -33.021M 44.29% | -55.973M -69.51% | -70.448M -25.86% | -28.349M 59.76% | -54.59M -92.57% | 6.544M 111.99% | 135.61M 1,972.28% | 536.41M 295.55% | 807.81M 50.60% | |
| Operating Margin | 25,769.57% | -3,103.48% | -11,517.08% | -9,866.71% | -656.98% | -78.53% | 4.58% | 43.89% | 60.92% | 64.57% | |
| EPS YoY % growth | -8.65 -202.45% | N/A 81.16% | -1.66 -2.00% | -1.70 -2.29% | -1.96 -15.50% | -1.05 46.49% | 1.40 233.01% | 4.81 244.53% | 8.77 82.20% | 12.74 45.23% |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.53 -25.48% | -0.37 20.17% | -0.38 11.06% | -0.49 -5.26% | -0.49 6.13% | -0.51 -38.89% | -0.47 -22.12% |
| Revenue Q2Q % growth | 321.3K 75.57% | 239.7K 2.44% | 178.5K 1,090.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -16.567M -16.44% | -17.642M -16.68% | -18.237M -1.18% | -21.065M -33.29% | -21.373M -29.01% | -21.456M -21.62% | -21.284M -16.71% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2026 Q2Q % growth | -0.47 -34.29% | -0.48 | 0.01 | 2.65% |
| Q4 2025 Q2Q % growth | -0.43 -72.80% | -0.51 | 0.07 | 14.73% |
| Q3 2025 Q2Q % growth | -0.46 -109.09% | -0.52 | 0.06 | 11.57% |
| Q2 2025 Q2Q % growth | -0.42 36.36% | -0.40 | -0.02 | -5.58% |
| Q1 2025 Q2Q % growth | -0.35 -1,043.79% | -0.41 | 0.06 | 15.27% |
| Q4 2024 Q2Q % growth | -0.25 85.71% | -0.37 | 0.12 | 32.39% |
| Q3 2024 Q2Q % growth | -0.22 85.33% | -0.31 | 0.09 | 28.70% |
| Q2 2024 Q2Q % growth | -0.66 72.50% | -0.69 | 0.03 | 4.84% |
| Q1 2024 Q2Q % growth | 98.98% | -0.03 | % | |
| Q4 2023 Q2Q % growth | -1.75 35.19% | -1.53 | -0.22 | -14.38% |
| Q3 2023 Q2Q % growth | -1.50 -2,900.00% | -2.14 | 0.64 | 29.97% |
| Q2 2023 Q2Q % growth | -2.40 -3,328.57% | -2.04 | -0.36 | -17.64% |
| Q1 2023 Q2Q % growth | -3.00 -7,400.00% | -2.30 | -0.71 | -30.72% |
| Q4 2022 Q2Q % growth | -2.70 -1,250.00% | -1.76 | -0.94 | -53.45% |
| Q3 2022 Q2Q % growth | -0.05 28.57% | -0.07 | 0.02 | 32.39% |
| Q2 2022 Q2Q % growth | -0.07 -40.00% | -0.06 | -0.01 | -19.35% |
| Q1 2022 Q2Q % growth | -0.04 42.86% | -0.05 | 0.01 | 26.47% |
| Q4 2021 Q2Q % growth | -0.20 -185.71% | -0.05 | -0.15 | -292.16% |
| Q3 2021 Q2Q % growth | -0.07 53.33% | -0.05 | -0.02 | -28.68% |
| Q2 2021 Q2Q % growth | -0.05 61.54% | -0.02 | -0.03 | -110.11% |
| Q1 2021 Q2Q % growth | -0.07 53.33% | -0.13 | 0.06 | 45.10% |
| Q4 2020 Q2Q % growth | -0.07 58.82% | -0.08 | 0.01 | 14.22% |
| Q3 2020 Q2Q % growth | -0.15 37.50% | -0.07 | -0.08 | -110.08% |
| Q2 2020 Q2Q % growth | -0.13 56.67% | -0.14 | 0.01 | 5.59% |
| Q1 2020 Q2Q % growth | -0.15 25.00% | -0.11 | -0.04 | -33.69% |
| Q4 2019 Q2Q % growth | -0.17 | -0.12 | -0.05 | -38.89% |
| Q3 2019 Q2Q % growth | -0.24 | -0.22 | -0.02 | -9.44% |
| Q2 2019 Q2Q % growth | -0.30 | -0.17 | -0.13 | -73.01% |
| Q1 2019 Q2Q % growth | -0.20 | -0.14 | -0.06 | -40.06% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2026 Q2Q % growth | 244K 190.48% | 663K | -419K | -63.20% |
| Q4 2025 Q2Q % growth | 15K -92.39% | 321.3K | -306.3K | -95.33% |
| Q3 2025 Q2Q % growth | 234K -43.12% | 183.6K | 50.4K | 27.45% |
| Q2 2025 Q2Q % growth | 183K -34.10% | 227.797K | -44.797K | -19.67% |
| Q1 2025 Q2Q % growth | 84K -53.33% | 306K | -222K | -72.55% |
| Q4 2024 Q2Q % growth | 197K 12.19% | 206.805K | -9.805K | -4.74% |
| Q3 2024 Q2Q % growth | 411.4K 128.56% | 555.39K | -143.99K | -25.93% |
| Q2 2024 Q2Q % growth | 277.7K 131.20% | 181.56K | 96.14K | 52.95% |
| Q1 2024 Q2Q % growth | 180K -41.94% | 188.7K | -8.7K | -4.61% |
| Q4 2023 Q2Q % growth | 175.6K 339.00% | 175.6K | % | |
| Q3 2023 Q2Q % growth | 180K -50.00% | 158.1K | 21.9K | 13.85% |
| Q2 2023 Q2Q % growth | -890K -347.22% | 316.2K | -1.206M | -381.47% |
| Q1 2023 Q2Q % growth | 310K -11.43% | 345.27K | -35.27K | -10.22% |
| Q4 2022 Q2Q % growth | 40K -90.91% | 359.723K | -319.723K | -88.88% |
| Q3 2022 Q2Q % growth | 360K 16.13% | 259.08K | 100.92K | 38.95% |
| Q2 2022 Q2Q % growth | 360K 9.09% | 268.77K | 91.23K | 33.94% |
| Q1 2022 Q2Q % growth | 350K | 388.283K | -38.283K | -9.86% |
| Q4 2021 Q2Q % growth | 440K | 233.07K | 206.93K | 88.78% |
| Q3 2021 Q2Q % growth | 310K | 215.557K | 94.443K | 43.81% |
| Q2 2021 Q2Q % growth | 330K | 1.7M | -1.37M | -80.59% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | -1.59% |
| Revenue | 0% | 0% | 0% | 37.21% |